{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:50:50Z","timestamp":1788288650327,"version":"build-2803163510"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Among people with Parkinson\u2019s disease (PD), non-motor symptoms (NMS) are a well-recognised cause of significant morbidity and poor quality of life. Yet, it is only more recently that NMS have been recognised to affect the lives of patients with atypical parkinsonian syndromes in a similar fashion. The aim of this article is to highlight and compare the relative prevalence of NMS among patients with atypical parkinsonian syndromes in the published literature, which largely remain underreported and unaddressed in routine clinical practice. All NMS that are recognised to occur in PD are also found to commonly occur in atypical parkinsonian syndromes. In particular, excessive daytime sleepiness is more prevalent among atypical parkinsonian syndromes (94.3%) compared to PD (33.9%) or normal controls (10.5%) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Urinary dysfunction (not limited to urinary incontinence) is not only found to occur in MSA (79.7%) and PD (79.9%), but has also been reported in nearly half of the patients with PSP (49.3%), DLB (42%) and CBD (53.8%) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Apathy is significantly more common among the atypical parkinsonian syndromes [PSP (56%), MSA (48%), DLB (44%), CBD (43%)] compared to PD (35%) (<jats:italic>p<\/jats:italic>\u2009=\u20090.029). Early recognition and addressing of NMS among atypical parkinsonian syndromes may help improve the holistic patient care provided and may encompass a range of conservative and pharmacotherapeutic treatments to address these symptoms.<\/jats:p>","DOI":"10.1007\/s00415-023-11807-x","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T03:28:01Z","timestamp":1686799681000},"page":"4558-4578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neurological update: non-motor symptoms in atypical parkinsonian syndromes"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-8991","authenticated-orcid":false,"given":"Piriyankan","family":"Ananthavarathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Peeros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Obrocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"11807_CR1","first-page":"1285","volume-title":"International review of neurobiology","author":"KP Bhatia","year":"2017","unstructured":"Bhatia KP, Stamelou M (2017) Chapter forty-six\u2014nonmotor features in atypical Parkinsonism. In: Chaudhuri KR, Titova N (eds) International review of neurobiology. Academic Press, New York, pp 1285\u20131301"},{"issue":"1","key":"11807_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00415-009-5255-7","volume":"257","author":"C Colosimo","year":"2009","unstructured":"Colosimo C, Morgante L, Antonini A et al (2009) Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol 257(1):5. https:\/\/doi.org\/10.1007\/s00415-009-5255-7","journal-title":"J Neurol"},{"issue":"1","key":"11807_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2047-9158-4-1","volume":"4","author":"H Chen","year":"2015","unstructured":"Chen H, Zhao EJ, Zhang W et al (2015) Meta-analyses on prevalence of selected Parkinson\u2019s nonmotor symptoms before and after diagnosis. Transl Neurodegener 4(1):1. https:\/\/doi.org\/10.1186\/2047-9158-4-1","journal-title":"Transl Neurodegener"},{"key":"11807_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.parkreldis.2020.10.003","volume":"81","author":"M Moscovich","year":"2020","unstructured":"Moscovich M, Heinzel S, Postuma RB et al (2020) How specific are non-motor symptoms in the prodrome of Parkinson\u2019s disease compared to other movement disorders? Parkinsonism Relat Disord 81:213\u2013218. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.10.003","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"11807_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jns.2013.01.034","volume":"327","author":"C-N Lee","year":"2013","unstructured":"Lee C-N, Kim M, Lee HM et al (2013) The interrelationship between non-motor symptoms in atypical parkinsonism. J Neurol Sci 327(1):15\u201321. https:\/\/doi.org\/10.1016\/j.jns.2013.01.034","journal-title":"J Neurol Sci"},{"issue":"3","key":"11807_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5(3):235\u2013245. https:\/\/doi.org\/10.1016\/s1474-4422(06)70373-8","journal-title":"Lancet Neurol"},{"issue":"11","key":"11807_CR7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00702-019-02055-3","volume":"126","author":"P Bugalho","year":"2019","unstructured":"Bugalho P, Ladeira F, Barbosa R et al (2019) Motor and non-motor function predictors of mortality in Parkinson\u2019s disease. J Neural Transm (Vienna) 126(11):1409\u20131415. https:\/\/doi.org\/10.1007\/s00702-019-02055-3","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"11807_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/psyg.12054","volume":"14","author":"C Ikeda","year":"2014","unstructured":"Ikeda C, Yokota O, Nagao S et al (2014) Corticobasal degeneration initially developing motor versus non-motor symptoms: a comparative clinicopathological study. Psychogeriatrics 14(3):152\u2013164. https:\/\/doi.org\/10.1111\/psyg.12054","journal-title":"Psychogeriatrics"},{"key":"11807_CR9","doi-asserted-by":"publisher","first-page":"106088","DOI":"10.1016\/j.clineuro.2020.106088","volume":"197","author":"A Gra\u017cy\u0144ska","year":"2020","unstructured":"Gra\u017cy\u0144ska A, Urba\u015b W, Antoniuk S et al (2020) Comparative analysis of non-motor symptoms in patients with Parkinson\u2019s Disease and atypical parkinsonisms. Clin Neurol Neurosurg 197:106088. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106088","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"11807_CR10","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/ene.14221","volume":"27","author":"D Santos-Garc\u00eda","year":"2020","unstructured":"Santos-Garc\u00eda D, de Deus FT, Su\u00e1rez Castro E et al (2020) Non-motor symptom burden is strongly correlated to motor complications in patients with Parkinson\u2019s disease. Eur J Neurol 27(7):1210\u20131223. https:\/\/doi.org\/10.1111\/ene.14221","journal-title":"Eur J Neurol"},{"key":"11807_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.parkreldis.2019.07.031","volume":"66","author":"D Santos Garc\u00eda","year":"2019","unstructured":"Santos Garc\u00eda D, de Deus FT, Su\u00e1rez Castro E et al (2019) Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson\u2019s disease patients: results from the COPPADIS Study Cohort. Parkinsonism Relat Disord 66:151\u2013157. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.07.031","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"11807_CR12","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.10583","volume":"18","author":"A Schrag","year":"2003","unstructured":"Schrag A, Selai C, Davis J, Lees AJ, Jahanshahi M, Quinn N (2003) Health-related quality of life in patients with progressive supranuclear palsy. Mov Disord 18(12):1464\u20131469. https:\/\/doi.org\/10.1002\/mds.10583","journal-title":"Mov Disord"},{"issue":"12","key":"11807_CR13","doi-asserted-by":"publisher","first-page":"e01135","DOI":"10.1002\/brb3.1135","volume":"8","author":"JJ Du","year":"2018","unstructured":"Du JJ, Wang T, Huang P et al (2018) Clinical characteristics and quality of life in Chinese patients with multiple system atrophy. Brain Behav 8(12):e01135. https:\/\/doi.org\/10.1002\/brb3.1135","journal-title":"Brain Behav"},{"issue":"1","key":"11807_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/0891988720968263","volume":"35","author":"S Kalampokini","year":"2020","unstructured":"Kalampokini S, Hommel ALAJ, Lorenzl S et al (2020) Caregiver burden in late-stage parkinsonism and its associations. J Geriatr Psychiatry Neurol 35(1):110\u2013120. https:\/\/doi.org\/10.1177\/0891988720968263","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"11","key":"11807_CR15","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1007\/s00415-018-9038-x","volume":"265","author":"G Santangelo","year":"2018","unstructured":"Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M (2018) Comparative cognitive and neuropsychiatric profiles between Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. J Neurol 265(11):2602\u20132613. https:\/\/doi.org\/10.1007\/s00415-018-9038-x","journal-title":"J Neurol"},{"key":"11807_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.10.002","volume":"45","author":"C Pellicano","year":"2017","unstructured":"Pellicano C, Assogna F, Cellupica N et al (2017) Neuropsychiatric and cognitive profile of early Richardson\u2019s syndrome, progressive supranuclear palsy-parkinsonism and Parkinson\u2019s disease. Parkinsonism Relat Disord 45:50\u201356. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.10.002","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"11807_CR17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00702-010-0563-8","volume":"118","author":"K Srulijes","year":"2011","unstructured":"Srulijes K, Mallien G, Bauer S et al (2011) In vivo comparison of Richardson\u2019s syndrome and progressive supranuclear palsy-parkinsonism. J Neural Transm (Vienna) 118(8):1191\u20131197. https:\/\/doi.org\/10.1007\/s00702-010-0563-8","journal-title":"J Neural Transm (Vienna)"},{"key":"11807_CR18","doi-asserted-by":"publisher","first-page":"9730319","DOI":"10.1155\/2016\/9730319","volume":"2016","author":"R Ou","year":"2016","unstructured":"Ou R, Song W, Wei Q et al (2016) Characteristics of nonmotor symptoms in progressive supranuclear palsy. Parkinson\u2019s disease 2016:9730319\u20139730319. https:\/\/doi.org\/10.1155\/2016\/9730319","journal-title":"Parkinson\u2019s disease"},{"key":"11807_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41531-017-0037-x","volume":"3","author":"FG Radicati","year":"2017","unstructured":"Radicati FG, Martinez Martin P, Fossati C et al (2017) Non motor symptoms in progressive supranuclear palsy: prevalence and severity. NPJ Parkinsons Dis 3:35. https:\/\/doi.org\/10.1038\/s41531-017-0037-x","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"11807_CR20","doi-asserted-by":"publisher","first-page":"e57221","DOI":"10.1371\/journal.pone.0057221","volume":"8","author":"K Ray Chaudhuri","year":"2013","unstructured":"Ray Chaudhuri K, Rojo JM, Schapira AHV et al (2013) A proposal for a comprehensive grading of Parkinson\u2019s disease severity combining motor and non-motor assessments: meeting an unmet need. PLoS ONE 8(2):e57221\u2013e57221. https:\/\/doi.org\/10.1371\/journal.pone.0057221","journal-title":"PLoS ONE"},{"issue":"2","key":"11807_CR21","first-page":"1","volume":"33","author":"GG Kataria","year":"2018","unstructured":"Kataria GG, Goyal V (2018) Non motor symptoms in parkinsonism: a cross sectional study. Mov Disord 33(2):1","journal-title":"Mov Disord"},{"key":"11807_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.parkreldis.2022.01.004","volume":"95","author":"D Street","year":"2022","unstructured":"Street D, Whiteside D, Rittman T, Rowe JB (2022) Prediagnostic progressive supranuclear palsy\u2014insights from the UK Biobank. Parkinsonism Relat Disord 95:59\u201364. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.01.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"11807_CR23","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/jnnp-2012-303618","volume":"84","author":"T Rittman","year":"2013","unstructured":"Rittman T, Ghosh BC, McColgan P et al (2013) The Addenbrooke\u2019s cognitive examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders. J Neurol Neurosurg Psychiatry 84(5):544\u2013551. https:\/\/doi.org\/10.1136\/jnnp-2012-303618","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"11807_CR24","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/brain\/awx101","volume":"140","author":"CJ Lansdall","year":"2017","unstructured":"Lansdall CJ, Coyle-Gilchrist ITS, Jones PS et al (2017) Apathy and impulsivity in frontotemporal lobar degeneration syndromes. Brain 140(6):1792\u20131807. https:\/\/doi.org\/10.1093\/brain\/awx101","journal-title":"Brain"},{"issue":"14","key":"11807_CR25","doi-asserted-by":"publisher","first-page":"e1547","DOI":"10.1212\/wnl.0000000000007249","volume":"92","author":"CJ Lansdall","year":"2019","unstructured":"Lansdall CJ, Coyle-Gilchrist ITS, Rodr\u00edguez PV et al (2019) Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration. Neurology 92(14):e1547\u2013e1557. https:\/\/doi.org\/10.1212\/wnl.0000000000007249","journal-title":"Neurology"},{"issue":"12","key":"11807_CR26","doi-asserted-by":"publisher","first-page":"e1066","DOI":"10.1212\/wnl.0000000000005175","volume":"90","author":"CJ Lansdall","year":"2018","unstructured":"Lansdall CJ, Coyle-Gilchrist ITS, Jones PS et al (2018) White matter change with apathy and impulsivity in frontotemporal lobar degeneration syndromes. Neurology 90(12):e1066\u2013e1076. https:\/\/doi.org\/10.1212\/wnl.0000000000005175","journal-title":"Neurology"},{"key":"11807_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad105","author":"D Street","year":"2023","unstructured":"Street D, Jabbari E, Costantini A et al (2023) Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials. Brain. https:\/\/doi.org\/10.1093\/brain\/awad105","journal-title":"Brain"},{"issue":"4","key":"11807_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/13554790590963004","volume":"11","author":"KA Josephs","year":"2005","unstructured":"Josephs KA, Boeve BF, Duffy JR et al (2005) Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 11(4):283\u2013296. https:\/\/doi.org\/10.1080\/13554790590963004","journal-title":"Neurocase"},{"issue":"1","key":"11807_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000191307.69661.c3","volume":"66","author":"KA Josephs","year":"2006","unstructured":"Josephs KA, Petersen RC, Knopman DS et al (2006) Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66(1):41\u201348. https:\/\/doi.org\/10.1212\/01.wnl.0000191307.69661.c3","journal-title":"Neurology"},{"issue":"6","key":"11807_CR30","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.20873","volume":"59","author":"MS Forman","year":"2006","unstructured":"Forman MS, Farmer J, Johnson JK et al (2006) Frontotemporal dementia: clinicopathological correlations. Ann Neurol 59(6):952\u2013962. https:\/\/doi.org\/10.1002\/ana.20873","journal-title":"Ann Neurol"},{"issue":"Pt 6","key":"11807_CR31","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/brain\/awl078","volume":"129","author":"KA Josephs","year":"2006","unstructured":"Josephs KA, Duffy JR, Strand EA et al (2006) Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129(Pt 6):1385\u20131398. https:\/\/doi.org\/10.1093\/brain\/awl078","journal-title":"Brain"},{"issue":"Pt 5","key":"11807_CR32","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/brain\/awn065","volume":"131","author":"SS O'Sullivan","year":"2008","unstructured":"O\u2019Sullivan SS, Massey LA, Williams DR et al (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131(Pt 5):1362\u20131372. https:\/\/doi.org\/10.1093\/brain\/awn065","journal-title":"Brain"},{"key":"11807_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clineuro.2017.10.039","volume":"164","author":"LB Barcelos","year":"2018","unstructured":"Barcelos LB, Saad F, Giacominelli C et al (2018) Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy. Clin Neurol Neurosurg 164:121\u2013126. https:\/\/doi.org\/10.1016\/j.clineuro.2017.10.039","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"11807_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/0028-3886.107916","volume":"61","author":"SP Turaga","year":"2013","unstructured":"Turaga SP, Mridula R, Borgohain R (2013) Cerebral glucose metabolism, clinical, neuropsychological, and radiological profile in patients with corticobasal syndrome. Neurol India 61(1):7\u201311. https:\/\/doi.org\/10.4103\/0028-3886.107916","journal-title":"Neurol India"},{"issue":"9","key":"11807_CR35","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/wnl.55.9.1368","volume":"55","author":"A Kertesz","year":"2000","unstructured":"Kertesz A, Martinez-Lage P, Davidson W, Munoz DG (2000) The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55(9):1368\u20131375. https:\/\/doi.org\/10.1212\/wnl.55.9.1368","journal-title":"Neurology"},{"issue":"3","key":"11807_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/jnnp.2003.029595","volume":"76","author":"TH Bak","year":"2005","unstructured":"Bak TH, Rogers TT, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR (2005) Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 76(3):420\u2013422. https:\/\/doi.org\/10.1136\/jnnp.2003.029595","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"11807_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/13554790590962997","volume":"11","author":"TH Bak","year":"2005","unstructured":"Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR (2005) Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 11(4):268\u2013273. https:\/\/doi.org\/10.1080\/13554790590962997","journal-title":"Neurocase"},{"issue":"4","key":"11807_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000327169","volume":"31","author":"R Mathew","year":"2011","unstructured":"Mathew R, Bak TH, Hodges JR (2011) Screening for cognitive dysfunction in corticobasal syndrome: utility of Addenbrooke\u2019s cognitive examination. Dement Geriatr Cogn Disord 31(4):254\u2013258. https:\/\/doi.org\/10.1159\/000327169","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"11807_CR39","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1212\/WNL.0000000000009734","volume":"95","author":"S Nobutaka","year":"2020","unstructured":"Nobutaka S, Octavio AS, Otto P et al (2020) Clinical and pathologic features of cognitive-predominant corticobasal degeneration. Neurology 95(1):e35. https:\/\/doi.org\/10.1212\/WNL.0000000000009734","journal-title":"Neurology"},{"issue":"1\u20132","key":"11807_CR40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jns.2009.08.036","volume":"289","author":"A Kertesz","year":"2010","unstructured":"Kertesz A, McMonagle P (2010) Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci 289(1\u20132):138\u2013143. https:\/\/doi.org\/10.1016\/j.jns.2009.08.036","journal-title":"J Neurol Sci"},{"issue":"5","key":"11807_CR41","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/mds.25872","volume":"29","author":"JR Burrell","year":"2014","unstructured":"Burrell JR, Hodges JR, Rowe JB (2014) Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord 29(5):684\u2013693. https:\/\/doi.org\/10.1002\/mds.25872","journal-title":"Mov Disord"},{"issue":"4","key":"11807_CR42","doi-asserted-by":"publisher","first-page":"e61025","DOI":"10.1371\/journal.pone.0061025","volume":"8","author":"JR Burrell","year":"2013","unstructured":"Burrell JR, Hornberger M, Villemagne VL, Rowe CC, Hodges JR (2013) Clinical profile of PiB-positive corticobasal syndrome. PLoS ONE 8(4):e61025. https:\/\/doi.org\/10.1371\/journal.pone.0061025","journal-title":"PLoS ONE"},{"issue":"11","key":"11807_CR43","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1212\/wnl.44.11.2065","volume":"44","author":"A Kertesz","year":"1994","unstructured":"Kertesz A, Hudson L, Mackenzie IR, Munoz DG (1994) The pathology and nosology of primary progressive aphasia. Neurology 44(11):2065\u20132072. https:\/\/doi.org\/10.1212\/wnl.44.11.2065","journal-title":"Neurology"},{"issue":"Pt 5","key":"11807_CR44","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/brain\/117.5.1183","volume":"117","author":"JO Rinne","year":"1994","unstructured":"Rinne JO, Lee MS, Thompson PD, Marsden CD (1994) Corticobasal degeneration. A clinical study of 36 cases. Brain 117(Pt 5):1183\u20131196. https:\/\/doi.org\/10.1093\/brain\/117.5.1183","journal-title":"Brain"},{"issue":"4","key":"11807_CR45","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1212\/01.wnl.0000081230.09863.ed","volume":"61","author":"NL Graham","year":"2003","unstructured":"Graham NL, Bak T, Patterson K, Hodges JR (2003) Language function and dysfunction in corticobasal degeneration. Neurology 61(4):493\u2013499. https:\/\/doi.org\/10.1212\/01.wnl.0000081230.09863.ed","journal-title":"Neurology"},{"issue":"9","key":"11807_CR46","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1212\/wnl.53.9.1969","volume":"53","author":"DA Grimes","year":"1999","unstructured":"Grimes DA, Lang AE, Bergeron CB (1999) Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 53(9):1969\u20131974. https:\/\/doi.org\/10.1212\/wnl.53.9.1969","journal-title":"Neurology"},{"issue":"7","key":"11807_CR47","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archneur.55.7.957","volume":"55","author":"K Kompoliti","year":"1998","unstructured":"Kompoliti K, Goetz CG, Boeve BF et al (1998) Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 55(7):957\u2013961. https:\/\/doi.org\/10.1001\/archneur.55.7.957","journal-title":"Arch Neurol"},{"issue":"11","key":"11807_CR48","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/mds.10536","volume":"18","author":"NL Graham","year":"2003","unstructured":"Graham NL, Bak TH, Hodges JR (2003) Corticobasal degeneration as a cognitive disorder. Mov Disord 18(11):1224\u20131232. https:\/\/doi.org\/10.1002\/mds.10536","journal-title":"Mov Disord"},{"issue":"8","key":"11807_CR49","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/01.wnl.0000240215.43492.01","volume":"67","author":"P McMonagle","year":"2006","unstructured":"McMonagle P, Blair M, Kertesz A (2006) Corticobasal degeneration and progressive aphasia. Neurology 67(8):1444\u20131451. https:\/\/doi.org\/10.1212\/01.wnl.0000240215.43492.01","journal-title":"Neurology"},{"issue":"6","key":"11807_CR50","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.410400611","volume":"40","author":"C Bergeron","year":"1996","unstructured":"Bergeron C, Pollanen MS, Weyer L, Black SE, Lang AE (1996) Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 40(6):893\u2013900. https:\/\/doi.org\/10.1002\/ana.410400611","journal-title":"Ann Neurol"},{"issue":"4","key":"11807_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp-2011-300875","volume":"83","author":"R Mathew","year":"2012","unstructured":"Mathew R, Bak TH, Hodges JR (2012) Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry 83(4):405\u2013410. https:\/\/doi.org\/10.1136\/jnnp-2011-300875","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"11807_CR52","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/WCO.0b013e3283168ddd","volume":"21","author":"KA Josephs","year":"2008","unstructured":"Josephs KA, Duffy JR (2008) Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol 21(6):688\u2013692. https:\/\/doi.org\/10.1097\/WCO.0b013e3283168ddd","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"11807_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/archneur.1968.00470310034003","volume":"18","author":"JJ Rebeiz","year":"1968","unstructured":"Rebeiz JJ, Kolodny EH, Richardson EP Jr (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18(1):20\u201333. https:\/\/doi.org\/10.1001\/archneur.1968.00470310034003","journal-title":"Arch Neurol"},{"issue":"Pt 9","key":"11807_CR54","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/brain\/awh598","volume":"128","author":"A Kertesz","year":"2005","unstructured":"Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG (2005) The evolution and pathology of frontotemporal dementia. Brain 128(Pt 9):1996\u20132005. https:\/\/doi.org\/10.1093\/brain\/awh598","journal-title":"Brain"},{"issue":"11","key":"11807_CR55","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/mds.22558","volume":"24","author":"BP Shelley","year":"2009","unstructured":"Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH (2009) Is the pathology of corticobasal syndrome predictable in life? Mov Disord 24(11):1593\u20131599. https:\/\/doi.org\/10.1002\/mds.22558","journal-title":"Mov Disord"},{"issue":"8","key":"11807_CR56","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1212\/01.wnl.0000086814.35352.b3","volume":"61","author":"DF Tang-Wai","year":"2003","unstructured":"Tang-Wai DF, Josephs KA, Boeve BF, Dickson DW, Parisi JE, Petersen RC (2003) Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology 61(8):1134\u20131135. https:\/\/doi.org\/10.1212\/01.wnl.0000086814.35352.b3","journal-title":"Neurology"},{"issue":"Suppl 5","key":"11807_CR57","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/ana.10570","volume":"54","author":"BF Boeve","year":"2003","unstructured":"Boeve BF, Lang AE, Litvan I (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54(Suppl 5):S15\u2013S19. https:\/\/doi.org\/10.1002\/ana.10570","journal-title":"Ann Neurol"},{"key":"11807_CR58","first-page":"877","volume":"1994","author":"A Lang","year":"1994","unstructured":"Lang A, Riley D, Bergeron C (1994) Cortico-basal ganglionic degeneration. Neurodegener Dis 1994:877\u2013894","journal-title":"Neurodegener Dis"},{"issue":"5","key":"11807_CR59","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/jnnp.65.5.717","volume":"65","author":"I Litvan","year":"1998","unstructured":"Litvan I, Cummings JL, Mega M (1998) Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry 65(5):717\u2013721. https:\/\/doi.org\/10.1136\/jnnp.65.5.717","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"11807_CR60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/09540261.2013.766154","volume":"25","author":"MB Bruns","year":"2013","unstructured":"Bruns MB, Josephs KA (2013) Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy. Int Rev Psychiatry 25(2):197\u2013209. https:\/\/doi.org\/10.3109\/09540261.2013.766154","journal-title":"Int Rev Psychiatry"},{"issue":"1","key":"11807_CR61","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/wnl.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 89(1):88\u2013100. https:\/\/doi.org\/10.1212\/wnl.0000000000004058","journal-title":"Neurology"},{"key":"11807_CR62","doi-asserted-by":"publisher","first-page":"976753","DOI":"10.3389\/fnhum.2022.976753","volume":"16","author":"J Gan","year":"2022","unstructured":"Gan J, Liu S, Wang F et al (2022) Association between prevalence rate of dementia with Lewy bodies and sleep characteristics in Chinese old adults. Front Hum Neurosci 16:976753. https:\/\/doi.org\/10.3389\/fnhum.2022.976753","journal-title":"Front Hum Neurosci"},{"issue":"14","key":"11807_CR63","doi-asserted-by":"publisher","first-page":"e1547","DOI":"10.1212\/wnl.0000000000007249","volume":"92","author":"CJ Lansdall","year":"2019","unstructured":"Lansdall CJ, Coyle-Gilchrist ITS, V\u00e1zquez Rodr\u00edguez P et al (2019) Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration. Neurology 92(14):e1547\u2013e1557. https:\/\/doi.org\/10.1212\/wnl.0000000000007249","journal-title":"Neurology"},{"issue":"11","key":"11807_CR64","doi-asserted-by":"publisher","first-page":"e46327","DOI":"10.1371\/journal.pone.0046327","volume":"7","author":"IJ Higginson","year":"2012","unstructured":"Higginson IJ, Gao W, Saleem TZ et al (2012) Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factors. PLoS ONE 7(11):e46327. https:\/\/doi.org\/10.1371\/journal.pone.0046327","journal-title":"PLoS ONE"},{"key":"11807_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.parkreldis.2016.12.007","volume":"35","author":"L Zhang","year":"2017","unstructured":"Zhang L, Cao B, Ou R et al (2017) Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes. Parkinsonism Relat Disord 35:63\u201368. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.12.007","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"11807_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000339363","volume":"33","author":"Y Chiba","year":"2012","unstructured":"Chiba Y, Fujishiro H, Iseki E et al (2012) Retrospective survey of prodromal symptoms in dementia with Lewy bodies: comparison with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 33(4):273\u2013281. https:\/\/doi.org\/10.1159\/000339363","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"11807_CR67","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/mds.1120","volume":"16","author":"BF Boeve","year":"2001","unstructured":"Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16(4):622\u2013630. https:\/\/doi.org\/10.1002\/mds.1120","journal-title":"Mov Disord"},{"issue":"9","key":"11807_CR68","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1212\/WNL.0b013e31822c9148","volume":"77","author":"TJ Ferman","year":"2011","unstructured":"Ferman TJ, Boeve BF, Smith GE et al (2011) Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology 77(9):875\u2013882. https:\/\/doi.org\/10.1212\/WNL.0b013e31822c9148","journal-title":"Neurology"},{"issue":"5","key":"11807_CR69","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/ane.13488","volume":"144","author":"F Xu","year":"2021","unstructured":"Xu F, Wang H, Zhao Q et al (2021) Fatigue prevalence and associated factors in patients with multiple system atrophy. Acta Neurol Scand 144(5):553\u2013558. https:\/\/doi.org\/10.1111\/ane.13488","journal-title":"Acta Neurol Scand"},{"key":"11807_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29005","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L et al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"key":"11807_CR71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JPD-171254","volume":"8","author":"Y-H Lee","year":"2018","unstructured":"Lee Y-H, Lee J-E, Ryu D-W et al (2018) Urinary dysfunctions and post-void residual urine in typical and atypical Parkinson diseases. J Parkinsons Dis 8:145\u2013152. https:\/\/doi.org\/10.3233\/JPD-171254","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"11807_CR72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00702-009-0313-y","volume":"117","author":"M Reimann","year":"2010","unstructured":"Reimann M, Schmidt C, Herting B et al (2010) Comprehensive autonomic assessment does not differentiate between Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. J Neural Transm (Vienna) 117(1):69\u201376. https:\/\/doi.org\/10.1007\/s00702-009-0313-y","journal-title":"J Neural Transm (Vienna)"},{"issue":"8","key":"11807_CR73","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.parkreldis.2011.05.020","volume":"17","author":"AD Ha","year":"2011","unstructured":"Ha AD, Brown CH, York MK, Jankovic J (2011) The prevalence of symptomatic orthostatic hypotension in patients with Parkinson\u2019s disease and atypical parkinsonism. Parkinsonism Relat Disord 17(8):625\u2013628. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.05.020","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"11807_CR74","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10286-021-00825-2","volume":"31","author":"C Raccagni","year":"2021","unstructured":"Raccagni C, Indelicato E, Sidoroff V et al (2021) Female sexual dysfunction in multiple system atrophy: a prospective cohort study. Clin Auton Res 31(6):713\u2013717. https:\/\/doi.org\/10.1007\/s10286-021-00825-2","journal-title":"Clin Auton Res"},{"issue":"5","key":"11807_CR75","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1212\/wnl.43.5.962","volume":"43","author":"RL Doty","year":"1993","unstructured":"Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D (1993) Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson\u2019s disease. Neurology 43(5):962\u2013965. https:\/\/doi.org\/10.1212\/wnl.43.5.962","journal-title":"Neurology"},{"issue":"7","key":"11807_CR76","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/mds.28568","volume":"36","author":"HA Shill","year":"2021","unstructured":"Shill HA, Zhang N, Driver-Dunckley E, Mehta S, Adler CH, Beach TG (2021) Olfaction in neuropathologically defined progressive supranuclear palsy. Mov Disord 36(7):1700\u20131704. https:\/\/doi.org\/10.1002\/mds.28568","journal-title":"Mov Disord"},{"key":"11807_CR77","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/1471-2377-11-157","volume":"11","author":"M Suzuki","year":"2011","unstructured":"Suzuki M, Hashimoto M, Yoshioka M, Murakami M, Kawasaki K, Urashima M (2011) The odor stick identification test for Japanese differentiates Parkinson\u2019s disease from multiple system atrophy and progressive supra nuclear palsy. BMC Neurol 11:157. https:\/\/doi.org\/10.1186\/1471-2377-11-157","journal-title":"BMC Neurol"},{"issue":"8","key":"11807_CR78","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.neuropsychologia.2006.12.008","volume":"45","author":"S Luzzi","year":"2007","unstructured":"Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon Ralph MA (2007) Distinct patterns of olfactory impairment in Alzheimer\u2019s disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 45(8):1823\u20131831. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2006.12.008","journal-title":"Neuropsychologia"},{"issue":"10","key":"11807_CR79","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jamaoto.2021.2026","volume":"147","author":"R Lu","year":"2021","unstructured":"Lu R, Aziz NA, Reuter M, St\u00f6cker T, Breteler MMB (2021) Evaluation of the neuroanatomical basis of olfactory dysfunction in the general population. JAMA Otolaryngol Head Neck Surg 147(10):855\u2013863. https:\/\/doi.org\/10.1001\/jamaoto.2021.2026","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"9","key":"11807_CR80","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s00415-018-9049-7","volume":"266","author":"AQ Rana","year":"2019","unstructured":"Rana AQ, Qureshi AR, Siddiqui O, Sarfraz Z, Rana R, Shtilbans A (2019) Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis. J Neurol 266(9):2093\u20132102. https:\/\/doi.org\/10.1007\/s00415-018-9049-7","journal-title":"J Neurol"},{"issue":"4","key":"11807_CR81","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.31083\/j.jin2004108","volume":"20","author":"JY Chang","year":"2021","unstructured":"Chang JY, Rukavina K, Lawn T, Chaudhuri KR (2021) Pain in neurodegenerative diseases with atypical parkinsonism: a systematic review on prevalence, clinical presentation, and findings from experimental studies. J Integr Neurosci 20(4):1067\u20131078. https:\/\/doi.org\/10.31083\/j.jin2004108","journal-title":"J Integr Neurosci"},{"key":"11807_CR82","doi-asserted-by":"publisher","first-page":"3150306","DOI":"10.1155\/2019\/3150306","volume":"2019","author":"HY You","year":"2019","unstructured":"You HY, Wu L, Yang HT, Yang C, Ding XL (2019) A comparison of pain between Parkinson\u2019s disease and multiple system atrophy: a clinical cross-sectional survey. Pain Res Manag 2019:3150306. https:\/\/doi.org\/10.1155\/2019\/3150306","journal-title":"Pain Res Manag"},{"key":"11807_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/gps.5703","author":"CA Hamilton","year":"2022","unstructured":"Hamilton CA, Frith J, Donaghy PC et al (2022) Assessment of autonomic symptoms may assist with early\u00a0identification of mild cognitive impairment with Lewy bodies. Int J Geriatr Psychiatry. https:\/\/doi.org\/10.1002\/gps.5703","journal-title":"Int J Geriatr Psychiatry"},{"key":"11807_CR84","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.parkreldis.2021.03.015","volume":"89","author":"HS Ryu","year":"2021","unstructured":"Ryu HS, Kim HJ, You S et al (2021) Nocturnal stridor in multiple system atrophy: video-polysomnography and clinical features. Parkinsonism Relat Disord 89:48\u201353. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.03.015","journal-title":"Parkinsonism Relat Disord"},{"key":"11807_CR85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.sleep.2017.12.008","volume":"42","author":"S Rekik","year":"2018","unstructured":"Rekik S, Martin F, Dodet P et al (2018) Stridor combined with other sleep breathing disorders in multiple system atrophy: a tailored treatment? Sleep Med 42:53\u201360. https:\/\/doi.org\/10.1016\/j.sleep.2017.12.008","journal-title":"Sleep Med"},{"issue":"6","key":"11807_CR86","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/jamaneurol.2016.0412","volume":"73","author":"MA Santos-Santos","year":"2016","unstructured":"Santos-Santos MA, Mandelli ML, Binney RJ et al (2016) Features of patients with nonfluent\/agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration. JAMA Neurol 73(6):733\u2013742. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0412","journal-title":"JAMA Neurol"},{"issue":"8","key":"11807_CR87","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/mds.21992","volume":"23","author":"M K\u00f6llensperger","year":"2008","unstructured":"K\u00f6llensperger M, Geser F, Seppi K et al (2008) Red flags for multiple system atrophy. Mov Disord 23(8):1093\u20131099. https:\/\/doi.org\/10.1002\/mds.21992","journal-title":"Mov Disord"},{"issue":"5","key":"11807_CR88","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, R\u00fcb U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 110(5):517\u2013536. https:\/\/doi.org\/10.1007\/s00702-002-0808-2","journal-title":"J Neural Transm (Vienna)"},{"key":"11807_CR89","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.actbio.2021.03.071","volume":"132","author":"AJ Bindas","year":"2021","unstructured":"Bindas AJ, Kulkarni S, Koppes RA, Koppes AN (2021) Parkinson\u2019s disease and the gut: models of an emerging relationship. Acta Biomater 132:325\u2013344. https:\/\/doi.org\/10.1016\/j.actbio.2021.03.071","journal-title":"Acta Biomater"},{"issue":"21","key":"11807_CR90","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica R, Carlin JM, Grossardt BR et al (2009) Medical records documentation of constipation preceding Parkinson disease: a case\u2013control study. Neurology 73(21):1752\u20131758. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c34af5","journal-title":"Neurology"},{"issue":"4681","key":"11807_CR91","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1126\/science.6505700","volume":"226","author":"RL Doty","year":"1984","unstructured":"Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L (1984) Smell identification ability: changes with age. Science (New York, NY) 226(4681):1441\u20131443. https:\/\/doi.org\/10.1126\/science.6505700","journal-title":"Science (New York, NY)"},{"issue":"5","key":"11807_CR92","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/mds.22688","volume":"25","author":"L Silveira-Moriyama","year":"2010","unstructured":"Silveira-Moriyama L, Hughes G, Church A et al (2010) Hyposmia in progressive supranuclear palsy. Mov Disord 25(5):570\u2013577. https:\/\/doi.org\/10.1002\/mds.22688","journal-title":"Mov Disord"},{"issue":"7","key":"11807_CR93","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.parkreldis.2008.12.005","volume":"15","author":"A Haehner","year":"2009","unstructured":"Haehner A, Boesveldt S, Berendse HW et al (2009) Prevalence of smell loss in Parkinson\u2019s disease\u2014a multicenter study. Parkinsonism Relat Disord 15(7):490\u2013494. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.12.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"11807_CR94","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1600-0404.1995.tb06998.x","volume":"91","author":"GK Wenning","year":"1995","unstructured":"Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91(4):247\u2013250. https:\/\/doi.org\/10.1111\/j.1600-0404.1995.tb06998.x","journal-title":"Acta Neurol Scand"},{"key":"11807_CR95","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3389\/fneur.2018.00767","volume":"9","author":"T Yousaf","year":"2018","unstructured":"Yousaf T, Pagano G, Wilson H, Politis M (2018) Neuroimaging of sleep disturbances in movement disorders. Front Neurol 9:767. https:\/\/doi.org\/10.3389\/fneur.2018.00767","journal-title":"Front Neurol"},{"issue":"4","key":"11807_CR96","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1533317519828046","volume":"34","author":"A Boeve","year":"2019","unstructured":"Boeve A, Ferman TJ, Aakre J et al (2019) Excessive daytime sleepiness in major dementia syndromes. Am J Alzheimers Dis Other Demen 34(4):261\u2013264. https:\/\/doi.org\/10.1177\/1533317519828046","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"11","key":"11807_CR97","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1212\/wnl.0000000000001364","volume":"84","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Gagnon JF, Bertrand JA, G\u00e9nier Marchand D, Montplaisir JY (2015) Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology 84(11):1104\u20131113. https:\/\/doi.org\/10.1212\/wnl.0000000000001364","journal-title":"Neurology"},{"issue":"12","key":"11807_CR98","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH et al (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 30(12):1600\u20131611. https:\/\/doi.org\/10.1002\/mds.26431","journal-title":"Mov Disord"},{"issue":"3","key":"11807_CR99","first-page":"349","volume":"28","author":"I Arnulf","year":"2005","unstructured":"Arnulf I, Merino-Andreu M, Bloch F et al (2005) REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep 28(3):349\u2013354","journal-title":"Sleep"},{"issue":"3","key":"11807_CR100","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10286-020-00674-5","volume":"30","author":"SJ McCarter","year":"2020","unstructured":"McCarter SJ, Gehrking TL, St Louis EK et al (2020) Autonomic dysfunction and phenoconversion in idiopathic REM sleep behavior disorder. Clin Auton Res 30(3):207\u2013213. https:\/\/doi.org\/10.1007\/s10286-020-00674-5","journal-title":"Clin Auton Res"},{"issue":"9","key":"11807_CR101","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670\u2013676. https:\/\/doi.org\/10.1212\/01.wnl.0000324625.00404.15","journal-title":"Neurology"},{"issue":"11","key":"11807_CR102","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/mds.23826","volume":"26","author":"S Krishnan","year":"2011","unstructured":"Krishnan S, Sarma G, Sarma S, Kishore A (2011) Do nonmotor symptoms in Parkinson\u2019s disease differ from normal aging? Mov Disord 26(11):2110\u20132113. https:\/\/doi.org\/10.1002\/mds.23826","journal-title":"Mov Disord"},{"issue":"4","key":"11807_CR103","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/mdc3.12454","volume":"4","author":"N Malek","year":"2017","unstructured":"Malek N, Lawton MA, Grosset KA et al (2017) Autonomic dysfunction in early Parkinson\u2019s disease: results from the United Kingdom tracking Parkinson\u2019s study. Move Disord Clin Pract 4(4):509\u2013516. https:\/\/doi.org\/10.1002\/mdc3.12454","journal-title":"Move Disord Clin Pract"},{"issue":"5","key":"11807_CR104","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/jnnp.67.5.620","volume":"67","author":"GK Wenning","year":"1999","unstructured":"Wenning GK, Scherfler C, Granata R et al (1999) Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 67(5):620\u2013623. https:\/\/doi.org\/10.1136\/jnnp.67.5.620","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"11807_CR105","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/jnnp.63.5.584","volume":"63","author":"JM Senard","year":"1997","unstructured":"Senard JM, Ra\u00ef S, Lapeyre-Mestre M et al (1997) Prevalence of orthostatic hypotension in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 63(5):584\u2013589. https:\/\/doi.org\/10.1136\/jnnp.63.5.584","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"11807_CR106","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jamaneurol.2017.1125","volume":"74","author":"E De Pablo-Fernandez","year":"2017","unstructured":"De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT (2017) Association of autonomic dysfunction with disease progression and survival in Parkinson disease. JAMA Neurol 74(8):970\u2013976. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1125","journal-title":"JAMA Neurol"},{"issue":"4","key":"11807_CR107","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","volume":"67","author":"D Aarsland","year":"1999","unstructured":"Aarsland D, Larsen JP, Lim NG et al (1999) Range of neuropsychiatric disturbances in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 67(4):492\u2013496. https:\/\/doi.org\/10.1136\/jnnp.67.4.492","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11807_CR108","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.2147\/ndt.s178263","volume":"14","author":"D Belvisi","year":"2018","unstructured":"Belvisi D, Berardelli I, Suppa A et al (2018) Neuropsychiatric disturbances in atypical parkinsonian disorders. Neuropsychiatr Dis Treat 14:2643\u20132656. https:\/\/doi.org\/10.2147\/ndt.s178263","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"11807_CR109","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/mds.26208","volume":"30","author":"MG den Brok","year":"2015","unstructured":"den Brok MG, van Dalen JW, van Gool WA, Moll van Charante EP, de Bie RM, Richard E (2015) Apathy in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 30(6):759\u2013769. https:\/\/doi.org\/10.1002\/mds.26208","journal-title":"Mov Disord"},{"key":"11807_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11060729","author":"D Sipos-Lascu","year":"2021","unstructured":"Sipos-Lascu D, Vesa \u0218C, Perju-Dumbrav\u0103 L (2021) Apathy and anhedonia: clinical and neurophysiological assessment of a Romanian cohort. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci11060729","journal-title":"Brain Sci"},{"issue":"5","key":"11807_CR111","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1468-1331.1998.550443.x","volume":"5","author":"KH Karlsen","year":"1998","unstructured":"Karlsen KH, Larsen JP, Tandberg E, M\u00e6land JG (1998) Quality of life measurements in patients with Parkinson\u2019s disease: a community-based study. Eur J Neurol 5(5):443\u2013450. https:\/\/doi.org\/10.1046\/j.1468-1331.1998.550443.x","journal-title":"Eur J Neurol"},{"issue":"6","key":"11807_CR112","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000325829","volume":"8","author":"Y Winter","year":"2011","unstructured":"Winter Y, Spottke AE, Stamelou M et al (2011) Health-related quality of life in multiple system atrophy and progressive supranuclear palsy. Neurodegener Dis 8(6):438\u2013446. https:\/\/doi.org\/10.1159\/000325829","journal-title":"Neurodegener Dis"},{"issue":"1\u20132","key":"11807_CR113","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jad.2011.01.021","volume":"132","author":"NN Dissanayaka","year":"2011","unstructured":"Dissanayaka NN, Sellbach A, Silburn PA, O\u2019Sullivan JD, Marsh R, Mellick GD (2011) Factors associated with depression in Parkinson\u2019s disease. J Affect Disord 132(1\u20132):82\u201388. https:\/\/doi.org\/10.1016\/j.jad.2011.01.021","journal-title":"J Affect Disord"},{"issue":"4","key":"11807_CR114","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/08919887211018280","volume":"34","author":"GS Segal","year":"2021","unstructured":"Segal GS, Xie SJ, Paracha SU, Grossberg GT (2021) Psychosis in Parkinson\u2019s disease: current treatment options and impact on patients and caregivers. J Geriatr Psychiatry Neurol 34(4):274\u2013279. https:\/\/doi.org\/10.1177\/08919887211018280","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"5 Suppl","key":"11807_CR115","first-page":"S83","volume":"23","author":"D Fredericks","year":"2017","unstructured":"Fredericks D, Norton JC, Atchison C, Schoenhaus R, Pill MW (2017) Parkinson\u2019s disease and Parkinson\u2019s disease psychosis: a perspective on the challenges, treatments, and economic burden. Am J Manag Care 23(5 Suppl):S83\u2013S92","journal-title":"Am J Manag Care"},{"key":"11807_CR116","doi-asserted-by":"publisher","DOI":"10.1177\/0891988720988916","author":"K Badwal","year":"2021","unstructured":"Badwal K, Kiliaki SA, Dugani SB, Pagali SR (2021) Psychosis management in Lewy body dementia: a comprehensive clinical approach. J Geriatr Psychiatry Neurol. https:\/\/doi.org\/10.1177\/0891988720988916","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"11807_CR117","doi-asserted-by":"publisher","first-page":"9","DOI":"10.31887\/DCNS.2015.17.1\/wgaebel","volume":"17","author":"W Gaebel","year":"2015","unstructured":"Gaebel W, Zielasek J (2015) Focus on psychosis. Dialogues Clin Neurosci 17(1):9\u201318. https:\/\/doi.org\/10.31887\/DCNS.2015.17.1\/wgaebel","journal-title":"Dialogues Clin Neurosci"},{"issue":"6","key":"11807_CR118","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/jnnp.70.6.727","volume":"70","author":"J Barnes","year":"2001","unstructured":"Barnes J, David AS (2001) Visual hallucinations in Parkinson\u2019s disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 70(6):727\u2013733. https:\/\/doi.org\/10.1136\/jnnp.70.6.727","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"11807_CR119","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1017\/s0033291718003161","volume":"49","author":"CL Eversfield","year":"2019","unstructured":"Eversfield CL, Orton LD (2019) Auditory and visual hallucination prevalence in Parkinson\u2019s disease and dementia with Lewy bodies: a systematic review and meta-analysis. Psychol Med 49(14):2342\u20132353. https:\/\/doi.org\/10.1017\/s0033291718003161","journal-title":"Psychol Med"},{"key":"11807_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28745","author":"M Onofrj","year":"2021","unstructured":"Onofrj M, Di Iorio A, Carrarini C et al (2021) Preexisting bipolar disorder influences the subsequent phenotype of Parkinson\u2019s disease. Mov Disord. https:\/\/doi.org\/10.1002\/mds.28745","journal-title":"Mov Disord"},{"issue":"4","key":"11807_CR121","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/jnnp-2011-300980","volume":"83","author":"K Bertram","year":"2012","unstructured":"Bertram K, Williams DR (2012) Visual hallucinations in the differential diagnosis of parkinsonism. J Neurol Neurosurg Psychiatry 83(4):448\u2013452. https:\/\/doi.org\/10.1136\/jnnp-2011-300980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11807_CR122","unstructured":"Efficacy of RIVastigmine on motor, cognitive and behavioural impairment in progressive supranuclear palsy (RIVA-PSP). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02839642. Accessed 29 May 2023"},{"issue":"4","key":"11807_CR123","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1523\/jneurosci.2336-15.2016","volume":"36","author":"EG Gentry","year":"2016","unstructured":"Gentry EG, Henderson BW, Arrant AE et al (2016) Rho kinase inhibition as a therapeutic for progressive supranuclear palsy and corticobasal degeneration. J Neurosci 36(4):1316\u20131323. https:\/\/doi.org\/10.1523\/jneurosci.2336-15.2016","journal-title":"J Neurosci"},{"issue":"Pt 6","key":"11807_CR124","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/brain\/awm032","volume":"130","author":"LI Golbe","year":"2007","unstructured":"Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130(Pt 6):1552\u20131565. https:\/\/doi.org\/10.1093\/brain\/awm032","journal-title":"Brain"},{"issue":"Pt 7","key":"11807_CR125","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awq123","volume":"133","author":"H Ling","year":"2010","unstructured":"Ling H, O\u2019Sullivan SS, Holton JL et al (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133(Pt 7):2045\u20132057. https:\/\/doi.org\/10.1093\/brain\/awq123","journal-title":"Brain"},{"key":"11807_CR126","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a003913","author":"R Lamb","year":"2019","unstructured":"Lamb R, Rohrer JD, Real R et al (2019) A novel TBK1 mutation in a family with diverse frontotemporal dementia spectrum disorders. Cold Spring Harbor Mol Case Stud. https:\/\/doi.org\/10.1101\/mcs.a003913","journal-title":"Cold Spring Harbor Mol Case Stud"}],"updated-by":[{"DOI":"10.1007\/s00415-023-12139-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000}}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11807-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11807-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11807-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T23:04:50Z","timestamp":1703718290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11807-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":126,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["11807"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11807-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00415-023-12139-6","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00415-023-12139-6","URL":"https:\/\/doi.org\/10.1007\/s00415-023-12139-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PA is a Clinical Research Fellow at the National Hospital for Neurology and Neurosurgery (Queen Square), London in a post supported by Merck. BP, SP, RL, NM: report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}